Profile

Hi we’re Portal Innovations!

Hi we’re Neoplants!

Neoplants is a French synthetic biology startup that bioengineers houseplants—particularly pothos (Epipremnum aureum)—to purify indoor air by targeting volatile organic compounds (VOCs) like benzene and toluene. Their flagship product, Neo Px, combines genetically enhanced plants with a proprietary microbiome system, achieving up to 30 times greater air purification efficiency compared to traditional houseplants

Hi we’re BOLD Capital Partners!

Hi we’re Actym Therapeutics!

Actym Therapeutics is a clinical-stage biopharmaceutical company focused on transforming cancer treatment. The company has created a proprietary novel drug modality (STACT™ biological platform) that harnesses the power of a genetically modified bacterial vehicle designed to be safely systemically administered and deliver multiple therapeutic payloads that are amplified and produced locally at the disease site.

Hi we’re Pinnacle Seed!

Pinnacle Seed is a premier supplier of elite leafy green germplasm, dedicated to developing high-performing varieties that meet the evolving needs of growers, processors, and consumers. With decades of breeding expertise and a deep understanding of market requirements, Pinnacle Seed delivers innovative solutions for commercial agriculture across diverse growing environments. The company’s extensive germplasm collection and marker-assisted breeding program has established it as a trusted partner in the specialty crop sector.

Hi we’re TFBS Bioscience!

TFBS Bioscience Inc. (TFBS) was founded in 2016 as the first contract research organization providing biological testing in Taiwan after its spin-off from Development Center for Biotechnology, a government-sponsored research institute. TFBS offers manufacturing expertise in adeno-associated virus, lentivirus, and retrovirus. With the customization specialty and state-of-the-art facility, TFBS is the best partner offering clients a one-stop-shop solution for gene and cell therapy.

Hi we’re Shenzhen Xinchuang Yihe!

Hi we’re Everest VC!

Founded in September 2007, Everest VC operates offices in Beijing, Shenzhen and Shanghai, with worldwide investment coverage high-tech sectors including healthcare, semiconductors, AI, advanced manufacturing, automotive transportation, and new energy. To date, Everest has invested in 128 companies, including 38 listed enterprises, and over10 are in IPO approval or listing process. Over its 18-year journey, Everest has been consistently empowering innovative startups with rapid growth. Through strategic investment insights and professional strategies, Everest provides capital and resources to help these enterprises distinguish themselves in the market and achieve rapid expansion. Additionally, by launching venture capital funds, Everest enables investors to share the growth dividends of high-tech companies, gaining widespread trust and recognition within the investment industry.